(WASHINGTON, D.C.) — Soon, another vaccine may be shipping out across the U.S. to help combat the COVID-19 pandemic. In a unanimous vote from federal advisers, the Moderna vaccine was recommended for emergency authorization from the Food and Drug Administration.
That particular vaccine is recommended for people over the age of 18.
Called the Vaccines and Related Biological Products Advisory Committee, the panel comprised of independent advisors ruled that the Moderna vaccine is safe for general use and that it is more than 94 percent effective in staving off COVID-19’s more serious side effects.
The vaccine now awaits approval from the FDA and, once the green light is given, 5.9 million doses will immediately ship out.
Last week, Pfizer was granted emergency authorization to distribute its COVID-19 vaccine, where 6.4 million vials were shipped out nationwide.
A third vaccine could be on the way, as well, from Johnson & Johnson. The company stated that it should know if their vaccine is safe for public use in January and, should that be granted approval, will help speed up the timeline of having a majority of Americans vaccinated.
Currently, expectations are that immunizations should be complete by June. Doctor Anthony Fauci cautioned that Americans might not start experiencing flickers of normalcy until fall 2021.
The news comes as the U.S. crossed 17 million COVID-19 cases and over 310,000 deaths on Thursday, as reported by Johns Hopkins University.